Barry J Maron1, Philip R Fox2. 1. Minneapolis Heart Institute Foundation, 920 E. 28th Street, Suite 620, Minneapolis, MN 55407, USA. 2. Caspary Research Institute, The Animal Medical Center, 510 East 62nd Street, New York, NY 10065-7174, USA. Electronic address: philip.fox@amcny.org.
Abstract
OBJECTIVES: To highlight similarities in hypertrophic cardiomyopathy (HCM) that are shared between humans and domestic cats. METHODS: Contemporary clinical and scientific findings were selected from the literature. Evidence is provided to support the concept that HCM in humans and felines are fundamentally the same disease. RESULTS: A number of remarkable similarities have been reported in certain spontaneously occurring myocardial disorders in domestic animals that closely resemble the clinical and phenotypic features of their corresponding diseases in humans. Chief among these conditions are hypertrophic cardiomyopathy (HCM) in the cat as well as arrhythmic right ventricular cardiomyopathy in cats and Boxer dogs, and non-hypertrophied restrictive cardiomyopathy in cats. Hypertrophic cardiomyopathy occurs commonly in the cat where it is a prominent cause of congestive heart failure and cardiovascular disability. Its prevalence in certain breeds suggests that it is a familial condition. Despite some inter-species differences in the expression of HCM in man and cats, their phenotypic expressions are very similar, supporting the belief that they are essentially the same disease in both species. These similarities include marked disease heterogeneity with unexplained asymmetric left ventricular hypertrophy, histopathology that includes disorganized myocyte arrangement, microvascular disease, and interstitial fibrosis, and end-stage cardiac remodeling. In cats two causal mutations have been identified in the myosin binding protein C (MYBPC3), though in man, mutations associated with 11 genes encoding for cardiac sarcomeric proteins are responsible for HCM. CONCLUSIONS: Given the similarities of HCM in both cats and man, the study of feline HCM may help expand the understanding of disease pathophysiology and help lead to improved disease management.
OBJECTIVES: To highlight similarities in hypertrophic cardiomyopathy (HCM) that are shared between humans and domestic cats. METHODS: Contemporary clinical and scientific findings were selected from the literature. Evidence is provided to support the concept that HCM in humans and felines are fundamentally the same disease. RESULTS: A number of remarkable similarities have been reported in certain spontaneously occurring myocardial disorders in domestic animals that closely resemble the clinical and phenotypic features of their corresponding diseases in humans. Chief among these conditions are hypertrophic cardiomyopathy (HCM) in the cat as well as arrhythmic right ventricular cardiomyopathy in cats and Boxer dogs, and non-hypertrophied restrictive cardiomyopathy in cats. Hypertrophic cardiomyopathy occurs commonly in the cat where it is a prominent cause of congestive heart failure and cardiovascular disability. Its prevalence in certain breeds suggests that it is a familial condition. Despite some inter-species differences in the expression of HCM in man and cats, their phenotypic expressions are very similar, supporting the belief that they are essentially the same disease in both species. These similarities include marked disease heterogeneity with unexplained asymmetric left ventricular hypertrophy, histopathology that includes disorganized myocyte arrangement, microvascular disease, and interstitial fibrosis, and end-stage cardiac remodeling. In cats two causal mutations have been identified in the myosin binding protein C (MYBPC3), though in man, mutations associated with 11 genes encoding for cardiac sarcomeric proteins are responsible for HCM. CONCLUSIONS: Given the similarities of HCM in both cats and man, the study of feline HCM may help expand the understanding of disease pathophysiology and help lead to improved disease management.
Authors: Andrew E Messer; Jasmine Chan; Alex Daley; O'Neal Copeland; Steven B Marston; David J Connolly Journal: Front Physiol Date: 2017-06-08 Impact factor: 4.566
Authors: Kieran Borgeat; Stijn J M Niessen; Lois Wilkie; Norelene Harrington; David B Church; Virginia Luis Fuentes; David J Connolly Journal: PLoS One Date: 2018-03-29 Impact factor: 3.240
Authors: Philip R Fox; Bruce W Keene; Kenneth Lamb; Karsten A Schober; Valerie Chetboul; Virginia Luis Fuentes; Gerhard Wess; Jessie Rose Payne; Daniel F Hogan; Alison Motsinger-Reif; Jens Häggström; Emilie Trehiou-Sechi; Deborah M Fine-Ferreira; Reid K Nakamura; Pamela M Lee; Manreet K Singh; Wendy A Ware; Jonathan A Abbott; Geoffrey Culshaw; Sabine Riesen; Michele Borgarelli; Michael B Lesser; Nicole Van Israël; Etienne Côté; John E Rush; Barret Bulmer; Roberto A Santilli; Andrea C Vollmar; Maribeth J Bossbaly; Nadine Quick; Claudio Bussadori; Janice M Bright; Amara H Estrada; Dan G Ohad; Maria Josefa Fernández-Del Palacio; Jenifer Lunney Brayley; Denise S Schwartz; Christina M Bové; Sonya G Gordon; Seung Woo Jung; Paola Brambilla; N Sydney Moïse; Christopher D Stauthammer; Rebecca L Stepien; Cecilia Quintavalla; Christophe Amberger; Ferenc Manczur; Yong-Wei Hung; Remo Lobetti; Marie De Swarte; Alice Tamborini; Carmel T Mooney; Mark A Oyama; Andrey Komolov; Yoko Fujii; Romain Pariaut; Masami Uechi; Victoria Yukie Tachika Ohara Journal: J Vet Intern Med Date: 2018-04-16 Impact factor: 3.333
Authors: Ingrid van Hoek; Hannah Hodgkiss-Geere; Elizabeth F Bode; Julie Hamilton-Elliott; Paul Mõtsküla; Valentina Palermo; Yolanda Martinez Pereira; Geoff J Culshaw; Jeremy Laxalde; Joanna Dukes-McEwan Journal: J Vet Intern Med Date: 2020-10-29 Impact factor: 3.333